Bjørn Hansen & Nathaniel Morris are Enhancing Sexual Wellness with Technology – Podcast Episode #30 | Psychedelic Invest

On this episode of the Psychedelic Invest Podcast, host Bruce Eckfedlt is joined by Bjorn Hansen and Nathaniel Morris of Intiem.

Bjorn Hansen is the CEO of Intiem. An accomplished entrepreneur with a background in both pharmaceuticals and electrical engineering, Bjorn is passionate about the potential for cannabis, psychedelics, and AI to transform the sexual wellness space.

Nathaniel Morris is the Chief Innovation Officer of Intiem. With more than 20 years of experience, Nathaniel is a cannabis and psychedelic SME profiled on PBS, MSNBC, and The Discovery Channel, and author of Transforming Orgasms with Psychedelics, Cannabis & Science.

Subscribe for More Season Three

We still have three more episodes in season three. Stay tuned for more great conversations to come.

If you just found out about the podcast, we encourage you to check out the Psychedelic Invest Podcast page or subscribe to the show on your favorite audio platform to binge and catch up.

The Transcription is Coming Soon

FDA advisory committee says risks of Novo Nordisk’s once-weekly insulin outweigh benefits in type 1 diabetes patients

An FDA advisory committee on Friday voted not to recommend Novo Nordisk’s once-weekly insulin injection in type 1 diabetes patients. Novo has pitched its candidate

May 25, 2024

Despite Dem opposition, House committee advances pandemic preparedness bill sans drug shortage provisions

The House Energy & Commerce Committee advanced its pandemic preparedness reauthorization legislation Wednesday, despite firm opposition from the panel’s Democrats who also reintroduced their own

July 21, 2023

Eli Lilly, Insitro ink a new kind of AI drug development deal

Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. But the deal is a little different

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.